PET imaging with ⁸⁹Zr: from radiochemistry to the clinic - sprookjes - yvandenbroek - TriplyDB

PET imaging with ⁸⁹Zr: from radiochemistry to the clinic

PET imaging with ⁸⁹Zr: from radiochemistry to the clinic

http://www.wikidata.org/entity/Q36454584

about

Combination Radioimmunotherapy Approaches and Quantification of Immuno-PET Surface-Enhanced Raman Spectroscopy: A New Modality for Cancer Imaging Targeting MT1-MMP as an ImmunoPET-Based Strategy for Imaging Gliomas Site-Specifically Labeled Immunoconjugates for Molecular Imaging--Part 2: Peptide Tags and Unnatural Amino Acids Site-Specifically Labeled Immunoconjugates for Molecular Imaging--Part 1: Cysteine Residues and Glycans Novel Preparation Methods of (52)Mn for ImmunoPET Imaging Immune cell screening of a nanoparticle library improves atherosclerosis therapy Radioactive Nanomaterials for Multimodality Imaging Exploiting the Metal-Chelating Properties of the Drug Cargo for In Vivo Positron Emission Tomography Imaging of Liposomal Nanomedicines.Chromatographic separation of selenium and arsenic: A potential (72)Se/(72)As generator.Quantitative immunoPET of prostate cancer xenografts with 89Zr- and 124I-labeled anti-PSCA A11 minibody Alternative chelator for ⁸⁹Zr radiopharmaceuticals: radiolabeling and evaluation of 3,4,3-(LI-1,2-HOPO).Rational design, synthesis, and evaluation of tetrahydroxamic acid chelators for stable complexation of zirconium(IV)Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals.Positron emission tomography image-guided drug delivery: current status and future perspectives.Noninvasive Imaging of PSMA in prostate tumors with (89)Zr-Labeled huJ591 engineered antibody fragments: the faster alternatives Applying PET to broaden the diagnostic utility of the clinically validated CA19.9 serum biomarker for oncology.Improved modeling of in vivo kinetics of slowly diffusing radiotracers for tumor imaging.Tripodal tris(hydroxypyridinone) ligands for immunoconjugate PET imaging with (89)Zr(4+): comparison with desferrioxamine-B.Novel (89)Zr cell labeling approach for PET-based cell trafficking studies Novel Bifunctional Cyclic Chelator for (89)Zr Labeling-Radiolabeling and Targeting Properties of RGD Conjugates Chelator-Free Labeling of Layered Double Hydroxide Nanoparticles for in Vivo PET Imaging Optimization of a Pretargeted Strategy for the PET Imaging of Colorectal Carcinoma via the Modulation of Radioligand Pharmacokinetics.Nuclear molecular imaging with nanoparticles: radiochemistry, applications and translation.Bioorthogonal Fluorophore Linked DFO-Technology Enabling Facile Chelator Quantification and Multimodal Imaging of Antibodies.In Vitro and In Vivo Comparison of Selected Ga-68 and Zr-89 Labelled Siderophores.Pilot study of (89)Zr-bevacizumab positron emission tomography in patients with advanced non-small cell lung cancer Dual PET and Near-Infrared Fluorescence Imaging Probes as Tools for Imaging in Oncology.Preclinical 89Zr Immuno-PET of High-Grade Serous Ovarian Cancer and Lymph Node Metastasis.p-SCN-Bn-HOPO: A Superior Bifunctional Chelator for (89)Zr ImmunoPET H(4)octapa-trastuzumab: versatile acyclic chelate system for 111In and 177Lu imaging and therapy Interrogating tumor metabolism and tumor microenvironments using molecular positron emission tomography imaging. Theranostic approaches to improve therapeutics.Pretargeted PET Imaging Using a Site-Specifically Labeled Immunoconjugate.H6phospa-trastuzumab: bifunctional methylenephosphonate-based chelator with 89Zr, 111In and 177Lu.Imaging Axl expression in pancreatic and prostate cancer xenografts.Siderophores for molecular imaging applications.A physiological perspective on the use of imaging to assess the in vivo delivery of therapeutics.Preparation of clinical-grade (89) Zr-panitumumab as a positron emission tomography biomarker for evaluating epidermal growth factor receptor-targeted therapy.Zirconium tetraazamacrocycle complexes display extraordinary stability and provide a new strategy for zirconium-89-based radiopharmaceutical development.Tumour targeting with radiometals for diagnosis and therapy.

P2860

Q26747546-42ACC3F6-5333-41FB-8175-7DD1BE1F0859 Q26800122-ECB0386B-AEEE-4D77-81FB-3B6002129AF2 Q27335251-C6CEA31B-A076-4936-B9E3-774059690CE7 Q28076701-895B9F6A-DACE-4437-9D9F-D2F06CE3C299 Q28078378-314F6A60-9CBC-438F-BF7A-C944E80355ED Q28391928-FD9FE2C1-53BC-4784-BCA5-A2B93A1E4F7C Q28393434-B9F95A8E-9123-4A25-AFDC-D748789E5551 Q28833646-93B5AD0F-DEC8-44A3-899F-5E0F650E3BFD Q30829681-A9066EFA-074D-40EA-87F9-E8319E93852D Q33647373-B5E88C8A-5672-43E0-A3DD-E765BC6C1F7C Q33738280-F3200C28-1351-4E35-B03D-17DB3FD34D2E Q33761754-3251D7CB-1922-42EE-AED8-F338D133DD2A Q34009558-FA4AD4F1-D015-4AB3-8604-B7FEBDEB2727 Q34119201-023489CD-6E88-48EF-81C2-3BF6721E8CCA Q34446108-65AB1A31-A442-4A9F-AF73-68BA03A4F182 Q34473460-BE81395A-46B4-4101-A821-820630455262 Q34762185-4D92FBB5-68A0-46C1-B5D0-13762926266F Q35101117-AAC0756D-B2C7-46CA-9451-7A14B683B132 Q35170338-30D1B1D0-803D-4875-B0CA-EA5036C6872C Q35462110-EFE025DC-E2C8-4D29-98E5-1D23838ACA7B Q35676322-29F67D76-278D-4F93-870D-FD0FA56BC62C Q36301189-7880A60B-3A62-425B-A521-F82F8272E5E0 Q36418274-A93074F0-0E70-471C-A0A7-53D076C2F48D Q36514481-E95E8952-277B-462A-9357-4F049D5E9F94 Q36874190-B15EEAD7-2593-4F9B-9954-D538804C3D1D Q36909826-08263DB6-FADA-4E91-AC93-700AF7B7B8FF Q36944511-C88BF029-A92E-4BAE-BF98-EB542AA5357B Q37120903-84AE42FE-9944-4635-8034-AF79F903DF91 Q37122878-3FA13485-3FFC-42B4-8C36-67DE2BDD29DF Q37129847-FA0EADD3-2507-4E9F-8133-3995D0B94B0E Q37209655-508F919D-0939-4E41-853E-4BA0451D11BF Q37236103-34D9888F-9971-42B1-9B87-05A1D6B934F9 Q37403530-3030C500-B023-419F-AFDE-DC98CBC011C0 Q37412579-BB62E8D5-1456-4E2F-9719-8FB5C0B743AE Q37571724-EB4BDAAC-9ACE-41B5-A2A7-C175E1605950 Q37609134-DB760B2B-66E3-46A3-8271-8DC5A8BD17E6 Q37619943-17750AB8-F980-49C1-9FB1-F6D225A0CC18 Q37696236-A320BBA3-165A-4F5C-AC7C-43B3B05D3D71 Q37718007-F49F36B0-CACD-4155-8AA0-42B1A8C64DA0 Q38100112-ECD4C973-7F0F-42D7-B32C-793037BBA098

P2860

PET imaging with ⁸⁹Zr: from radiochemistry to the clinic

http://www.wikidata.org/entity/Q36454584

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

PET imaging with ⁸⁹Zr: from radiochemistry to the clinic

@ast

PET imaging with ⁸⁹Zr: from radiochemistry to the clinic

@en

type

label

PET imaging with ⁸⁹Zr: from radiochemistry to the clinic

@ast

PET imaging with ⁸⁹Zr: from radiochemistry to the clinic

@en

prefLabel

PET imaging with ⁸⁹Zr: from radiochemistry to the clinic

@ast

PET imaging with ⁸⁹Zr: from radiochemistry to the clinic

@en

P1433

Q36454584-ED1FAB84-BC10-4ECC-8D1B-18660EBE31E9

P1476

Q36454584-BC71EF23-F97E-4ADF-9F03-F505A27EE0D4

P2093

Q36454584-6E6A3EF1-52B0-4E8C-8183-131AE5495692

Q36454584-793CF1CF-DC52-4D49-9F3D-F8900E792F43

Q36454584-7B5D22F3-5B9E-44BA-A35C-2E8C2F97955A

P2860

Q36454584-0154287C-05C7-4B73-8EF5-034F1187D8ED

Q36454584-0B961FA8-B12B-4744-B45C-03D31778102F

Q36454584-0EA381A2-1DE8-4FD2-B963-B33B4EA1FD88

Q36454584-0EBA1161-73D8-4516-B775-3C610E974FC6

Q36454584-12959239-4023-40D6-ADE3-4C8C294EF5FD

Q36454584-17234664-C803-4E04-84C7-8F0F593FD580

Q36454584-17EC7A0A-B562-487B-82ED-963BDF26D6C7

Q36454584-26FCD933-B997-4645-B532-9D1F3EC77525

Q36454584-2BEEB928-752B-4C0F-9A63-C42D3BE41CE4

Q36454584-33057565-A879-4854-8A76-B94D322E25B5

P304

Q36454584-2785E4E1-FB8C-41C4-A97D-983195707E34

P31

Q36454584-FC60A5D0-9054-411A-A985-90926BE99AFB

P356

Q36454584-BCFD397C-B097-47C2-AEBE-CFFE232006C8

P433

Q36454584-5D64A6E3-2750-41DB-8ABD-EAD30A2ADE75

P478

Q36454584-C6EF77F6-12F1-4682-A245-B172456FF463

P50

Q36454584-23F0A78E-2D20-440B-80DF-5F29CADCF724

P577

Q36454584-2975CBCB-563A-44A4-A0B1-95D65F8FBF33

P5875

Q36454584-F1BBF7BD-42D0-4531-9A0A-5DA186408AC6

P698

Q36454584-A57CC31D-2F97-4681-9DC9-FA49895E6EE7

P932

Q36454584-E7FB8F25-0764-46E9-AD48-5613064D2CB8

P356

J.NUCMEDBIO.2012.08.004

P1433

Nuclear Medicine and Biology

P1476

PET imaging with ⁸⁹Zr: from radiochemistry to the clinic

@en

P2093

Brian M Zeglis

http://www.w3.org/2001/XMLSchema#string

Lynn C Francesconi

http://www.w3.org/2001/XMLSchema#string

Melissa A Deri

http://www.w3.org/2001/XMLSchema#string

P2860

Targeting the internal epitope of prostate-specific membrane antigen with 89Zr-7E11 immuno-PET

Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubes

Cerenkov luminescence imaging of medical isotopes.

Measuring the pharmacodynamic effects of a novel Hsp90 inhibitor on HER2/neu expression in mice using Zr-DFO-trastuzumab

PET of hypoxia with 89Zr-labeled cG250-F(ab')2 in head and neck tumors.

p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging

Standardized methods for the production of high specific-activity zirconium-89.

Zirconium - Phosphorus Chemistry: Strategies in Syntheses, Reactivity, Catalysis, and Utility.

Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease

Imaging of prostate cancer with immuno-PET and immuno-SPECT using a radiolabeled anti-EGP-1 monoclonal antibody.

P304

3-14

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NUCMEDBIO.2012.08.004

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257432223

http://www.w3.org/2001/XMLSchema#string

P698

22998840

http://www.w3.org/2001/XMLSchema#string

P932

3517725

http://www.w3.org/2001/XMLSchema#string